Lantheus Holdings, Inc

LNTHNASDAQ • USD
101.59 USD
↗ 0.34 (0.34%)AT CLOSE (03:59 PM EST)
101.60
↗ 0.01 (0.00%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
101.60
↗ 0.01 (0.00%)
🔴Market: CLOSED

Lantheus Holdings, Inc (LNTH) trades at $101.59 per share. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place LNTH at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$101.43
High?$101.75
Low?$101.20
Prev. Close?$101.25
Volume?758.0K
Avg. Volume?1.0M
VWAP?$101.55
Rel. Volume?0.74x
Bid / Ask
Bid?$100.01 × 100
Ask?$102.00 × 300
Spread?$1.99
Midpoint?$101.01
Valuation & Ratios
Market Cap?6.6B
Shares Out?65.4M
Float?63.8M
Float %?97.8%
P/E Ratio?24.62
P/B Ratio?4.90
EPS?$4.13
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Employees
1.2K
Market Cap
6.6B
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed
2015-06-25
Address
201 BURLINGTON ROAD, SOUTH BUILDING
BEDFORD, MA 01730
Phone: 978 671-8001
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
99
Momentum?
85
Short Sent.?
49
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.54Safe
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.70%Elevated
Short Interest?3.6M
Days to Cover?3.2
Free Float63.8M
Avg Daily Volume1.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.25Strong
Quick Ratio?3.06Strong
Cash Ratio?1.98Strong
Debt/Equity?0.42Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
72/100
P/E?
Peers
100
S&P
49
24.6FAIR▾
P/B?
Peers
100
S&P
37
4.90FAIR▾
P/S?
Peers
100
S&P
36
4.25FAIR▾
P/FCF?
Peers
100
S&P
67
16.9CHEAP▾
EV/EBITDA?
Peers
100
S&P
38
17.1FAIR▾
EV/Sales?
Peers
100
S&P
44
4.18FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
66
19.9%STRONG▾
ROA?
Peers
50
S&P
78
11.0%STRONG▾
Cash Flow & Enterprise
FCF?$393.1M
Enterprise Value?$6.5B
Fundamentals ratios updated end of day